1.0Cfm Oskar Tropitzsch GmbHhttps://www.cfmot.de/en/p490047https://www.cfmot.de/en/author/administrator/rich600338<blockquote class="wp-embedded-content" data-secret="18o5YR8M4F"><a href="https://www.cfmot.de/en/adcs/">ADCs</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cfmot.de/en/adcs/embed/#?secret=18o5YR8M4F" width="600" height="338" title="“ADCs” — Cfm Oskar Tropitzsch GmbH" data-secret="18o5YR8M4F" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.cfmot.de/wp-includes/js/wp-embed.min.js </script> https://www.cfmot.de/wp-content/uploads/2019/01/adc_amanita_phalloides.jpg1200797Innovationen for a better world We supply the keys to new therapies Antibody Drug Conjugates (ADCs) are a new approach in the development of innovative drugs for cancer therapy. This fundamental technology has already been described in 1908 by Paul Ehrlich and awarded with the Nobel Prize in Medicine. Human antibodies are coupled to highly […]